The Spanish Society of Rheumatology (SER) has launched the Study of the epidemiology of osteoporosis in Spain (OsteoSER), in order to know the magnitude of the problem of fragility fractures as a result of this disease, which is the most frequent of bone mineral metabolism. In fact, it is estimated that it affects approximately 2.5 million Spaniards over 50 years of age. For all these reasons, it is essential to predict who will present a fragility fracture and establish prevention protocols, and for this it is necessary to have effective and up-to-date tools to calculate the risk of fracture for each patient.
It is key to predict who will present a fragility fracture and establish prevention protocols.
Thus, this study presented by the SER is established as “a first step to be able to adapt health policies to the specific situation of our country”, explains Dr. Carmen Gomez Vaquero, rheumatologist at the Hospital Universitari de Bellvitge (L’Hospitalet) and principal investigator of this project.
cost of osteoporosis
The cost of osteoporosis in the European Union in 2010 stood at 37,000 million euros, of which the costs of treating incident fractures represented 66%, pharmacological prevention 5%, and long-term fracture care 29%. For this reason, “in Western countries one of the health objectives isPrimary and secondary prevention of fragility fracture”, specifies the specialist.
The cost of osteoporosis in the European Union in 2010 stood at 37,000 million euros.
In Spain, the age-adjusted incidence of hip fracture is decreasing, partly due to the health interventions that are being carried out and also due to the cohort effect. The great variability that exists between autonomous communities would be justified, in addition to genetic, demographic and climatic factorsdue to the cohort effect associated with the Civil War.
In the opinion of Dr. Gómez Vaquero, “it seems necessary, therefore, update data with which the fracture risk of patients is calculated”. In addition, “techniques for assessing bone quality and body composition have been developed that can complement the predictive value of bone mineral density on fracture risk and have been included in OsteoSER.”
Objectives of OsteoSER
The main objective of OsteoSER is to estimate the distribution of bone mass and architecture parameters and body composition to obtain updated normality curves of Bone mineral density and body composition in the Spanish population between 20 and 80 years.
“We will be able to calculate the fracture risk of the Spanish population between 40 and 80 years of age with the FRAX tool”.
“As secondary objectives, we set out to estimate the prevalence of osteoporosis, fragility fractures, vertebral fractures by Vertebral Fracture Assessment and sarcopenia. Likewise, we will be able to calculate the fracture risk of the Spanish population between 40 and 80 years of age with the FRAX tool”, points out Dr. Gómez Vaquero.
The study involved rheumatologists from six representative provinces of the areas with high and medium/low risk of hip fracture in Spain. The specified provinces are Alicante, Badajoz, Barcelona, A Coruña, Madrid and Malaga. Within the reference area of the hospital of each rheumatologist, one urban and one rural municipality were randomly selected and, subsequently, the coordinators of the Primary Care centers were contacted.
The study involved rheumatologists from six representative provinces of the areas with high and medium/low risk of hip fracture in Spain.
During this month of July, the family doctors participating in this research have begun to recruit patients and to collect (in an electronic CRD) information on sociodemographic variables, life habits, fracture risk factors, pathological antecedents and treatments.
Initially, it is expected to include 1,638 subjects, stratified by sex and decade of age.
In early October 2022, a vehicle with a densitometer installed It will travel to each of the selected towns and will be located in an accessible location assigned by the city council. Initially, it is expected to include 1,638 subjects, stratified by sex and decade of age.
The research is financially supported by Hologic, Stada Y UCB.
#OsteoSER #study #reveal #epidemiological #situation #osteoporosis #Spain #Pharma #Market #Magazine